228 related articles for article (PubMed ID: 27371157)
21. Strategic manipulations for associative memory and the role of verbal processing abilities in schizophrenia.
Bonner-Jackson A; Barch DM
J Int Neuropsychol Soc; 2011 Sep; 17(5):796-806. PubMed ID: 21729401
[TBL] [Abstract][Full Text] [Related]
22. Nicotine effects on brain function and functional connectivity in schizophrenia.
Jacobsen LK; D'Souza DC; Mencl WE; Pugh KR; Skudlarski P; Krystal JH
Biol Psychiatry; 2004 Apr; 55(8):850-8. PubMed ID: 15050867
[TBL] [Abstract][Full Text] [Related]
23. A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
Bain EE; Apostol G; Sangal RB; Robieson WZ; McNeill DL; Abi-Saab WM; Saltarelli MD
J Clin Psychiatry; 2012 Jun; 73(6):783-9. PubMed ID: 22795204
[TBL] [Abstract][Full Text] [Related]
24. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.
Jucaite A; Öhd J; Potter AS; Jaeger J; Karlsson P; Hannesdottir K; Boström E; Newhouse PA; Paulsson B
Psychopharmacology (Berl); 2014 Mar; 231(6):1251-65. PubMed ID: 23640072
[TBL] [Abstract][Full Text] [Related]
26. A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia.
Arce E; Balice-Gordon R; Duvvuri S; Naylor M; Xie Z; Harel B; Kozak R; Gray DL; DeMartinis N
J Psychopharmacol; 2019 Oct; 33(10):1237-1247. PubMed ID: 31264510
[TBL] [Abstract][Full Text] [Related]
27. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
[TBL] [Abstract][Full Text] [Related]
28. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study.
Wilens TE; Verlinden MH; Adler LA; Wozniak PJ; West SA
Biol Psychiatry; 2006 Jun; 59(11):1065-70. PubMed ID: 16499880
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
[TBL] [Abstract][Full Text] [Related]
30. The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.
Haig G; Wang D; Othman AA; Zhao J
Neuropsychopharmacology; 2016 Nov; 41(12):2893-2902. PubMed ID: 27319970
[TBL] [Abstract][Full Text] [Related]
31. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence.
Driesen NR; Leung HC; Calhoun VD; Constable RT; Gueorguieva R; Hoffman R; Skudlarski P; Goldman-Rakic PS; Krystal JH
Biol Psychiatry; 2008 Dec; 64(12):1026-34. PubMed ID: 18823880
[TBL] [Abstract][Full Text] [Related]
32. Working memory in schizotypal personality disorder: fMRI activation and deactivation differences.
Vu MA; Thermenos HW; Terry DP; Wolfe DJ; Voglmaier MM; Niznikiewicz MA; McCarley RW; Seidman LJ; Dickey CC
Schizophr Res; 2013 Dec; 151(1-3):113-23. PubMed ID: 24161536
[TBL] [Abstract][Full Text] [Related]
33. A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.
Umbricht D; Keefe RS; Murray S; Lowe DA; Porter R; Garibaldi G; Santarelli L
Neuropsychopharmacology; 2014 Jun; 39(7):1568-77. PubMed ID: 24549101
[TBL] [Abstract][Full Text] [Related]
34. Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.
Kumari V; Aasen I; ffytche D; Williams SC; Sharma T
Neuroimage; 2006 Jan; 29(2):545-56. PubMed ID: 16181792
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
Haig GM; Wang D; Zhao J; Othman AA; Bain EE
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 28922590
[TBL] [Abstract][Full Text] [Related]
36. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
[TBL] [Abstract][Full Text] [Related]
37. Neuroanatomical mechanism on the effect of distraction in working memory maintenance in patients with schizophrenia.
Kim GW; Chung YC; Yang JC; Chung GH; Park TJ; Jeong GW
J Neuropsychiatry Clin Neurosci; 2015; 27(1):e1-9. PubMed ID: 25541862
[TBL] [Abstract][Full Text] [Related]
38. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.
Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A
Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184
[TBL] [Abstract][Full Text] [Related]
39. Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.
Moran LV; Stoeckel LE; Wang K; Caine CE; Villafuerte R; Calderon V; Baker JT; Ongur D; Janes AC; Evins AE; Pizzagalli DA
Psychopharmacology (Berl); 2018 Mar; 235(3):789-802. PubMed ID: 29181816
[TBL] [Abstract][Full Text] [Related]
40. Nicotinic acetylcholine receptors contribute to learning-induced metaplasticity in the hippocampus.
Becker B; Klein EM; Striepens N; Mihov Y; Schlaepfer TE; Reul J; Goossens L; Schruers K; Kendrick KM; Hurlemann R
J Cogn Neurosci; 2013 Jul; 25(7):986-97. PubMed ID: 23469888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
